The Public Health Department is offering a grant to continue birth defects surveillance in Kampala, Uganda, conducted in four main hospitals. The project aims to assess major external structural birth defects and research the potential association between maternal use of cotrimoxazole or ARTs and birth defects. This study will establish background rates of birth defects and provide insights into maternal medication use for HIV/AIDS treatment during pregnancy in Kampala. Closing Date: May 04, 2016.
Opportunity ID: 281932
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-GH-16-008 |
Funding Opportunity Title: | Hospital-based birth defects surveillance in Kampala, Uganda |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Mar 02, 2016 |
Last Updated Date: | Mar 03, 2016 |
Original Closing Date for Applications: | May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 03, 2016 |
Estimated Total Program Funding: | $3,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Private institutions of higher education |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Technical Information Management Section (TIMS)
Telephone 770-488-2700 ogstims@cdc.gov Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time Email:ogstims@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Updated Contact Information. | Mar 03, 2016 | |
Updated contact information. | Mar 03, 2016 | |
Mar 03, 2016 |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-GH-16-008 |
Funding Opportunity Title: | Hospital-based birth defects surveillance in Kampala, Uganda |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Mar 02, 2016 |
Last Updated Date: | Mar 03, 2016 |
Original Closing Date for Applications: | May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 03, 2016 |
Estimated Total Program Funding: | $3,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Private institutions of higher education |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Technical Information Management Section (TIMS)
Telephone 770-488-2700 ogstims@cdc.gov Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time Email:ogstims@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-GH-16-008 |
Funding Opportunity Title: | Hospital-based birth defects surveillance in Kampala, Uganda |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 03, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 03, 2016 |
Estimated Total Program Funding: | $3,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Private institutions of higher education |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC Technical Information Management Section (TIMS)
Telephone 770-488-2700 Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time Email:ogstims@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-GH-16-008 |
Funding Opportunity Title: | Hospital-based birth defects surveillance in Kampala, Uganda |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 1 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 03, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 04, 2016 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
Archive Date: | Jun 03, 2016 |
Estimated Total Program Funding: | $3,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education Private institutions of higher education |
Additional Information on Eligibility: |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Sharon Campolucci
ssc1@cdc.gov Email:ssc1@cdc.gov |
Related Documents
Folder 281932 Full Announcement-CDC-RFA-GH16-008 -> cdc-rfa-gh16-008.pdf
Packages
Agency Contact Information: | CDC Technical Information Management Section (TIMS) Telephone 770-488-2700 ogstims@cdc.gov Hours: Monday – Friday, 7am – 4:30pm U.S. Eastern Time Email: ogstims@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.067 | RFA-GH-16-008 | Hospital-based birth defects surveillance in Kampala, Uganda | PKG00221290 | Mar 02, 2016 | May 04, 2016 | View |
Package 1
Mandatory forms
281932 RR_SF424_2_0-2.0.pdf
281932 PHS398_CoverPageSupplement_2_0-2.0.pdf
281932 PerformanceSite_2_0-2.0.pdf
281932 RR_OtherProjectInfo_1_3-1.3.pdf
281932 RR_KeyPersonExpanded_2_0-2.0.pdf
281932 PHS398_ResearchPlan_2_0-2.0.pdf
Optional forms
281932 PHS398_CumulativeInclusionReport-1.0.pdf
281932 PlannedReport-1.0.pdf
281932 RR_SubawardBudget30_1_3-1.3.pdf
281932 PHS398_ModularBudget_1_2-1.2.pdf
281932 RR_Budget_1_3-1.3.pdf